Shock wave therapy after ankle arthrodesis
Recruiting
- Conditions
- Arthrodesis, ankle osteoarthritis, extracorporeal shock waves, delayed union, bone regeneration, enkelartrodese, artrose, enkel, drukgolftherapie, botregeneratie
- Registration Number
- NL-OMON28154
- Lead Sponsor
- Erasmus Medical Center, Department of Orthopaedics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 76
Inclusion Criteria
Primary talocrural arthrodesis
- 18 years or older
Exclusion Criteria
- Previous ipsilateral talocrural arthrodesis
- inability to walk
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Number of delayed unions at 12 weeks follow-up
- Secondary Outcome Measures
Name Time Method - Number of non-unions at 26 weeks after ankle arthrodesis<br /><br>- SF-36 and FAOS survey scores pre-operative and at 16 and 26 weeks. AOFAS survey score pre-operative and at 26 weeks.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does extracorporeal shock wave therapy activate to enhance bone regeneration in ankle arthrodesis?
How does shock wave therapy compare to standard-of-care interventions for delayed union in ankle osteoarthritis patients?
Which biomarkers correlate with successful bone healing outcomes in NL-OMON28154 shock wave therapy trials?
What are the long-term adverse events associated with ESWT in ankle arthrodesis, and how are they managed?
Are there combination therapies involving shock wave treatment and bone morphogenetic proteins for ankle fusion efficacy?